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ELISPOT assays are routinely used to measure immune
responses of T cells in fresh and frozen splenocytes pre-
parations; however, standardized methods for murine
ELISPOT are not widely available. Freezing cells can
significantly impact the function of T cells. The aim of
this study was to optimize cryopreservation protocols to
retain antigen-specific T cell function at similar levels as
freshly isolated T cells using murine splenocytes. We
examined four factors that might have an impact on cell
viability and function: freezing medium, resting cells
prior to freezing, temperature of the medium for initial
dilution of cells after thawing and resting of cells prior
to ELISPOT. FVB/N mice were vaccinated with adjuvant
only (CFA/IFA) or IGF-IR peptides, previously shown to
be immunogenic by ELISPOT analysis. Mouse spleno-
cytes were cryopreserved using five different media:
Medium 1 (50% X-Vivo media, 40% FBS, 10% DMSO),
Medium 2 (25% RMPI, 65% FBS, 10% DMSO), Medium
3 (90% FBS, 10% DMSO), Medium 4 (Amresco Media)
and Medium 5 (EZ-CP2 Media). Prior to freezing, the
cells were either rested on ice for 5 hours or immedi-
ately frozen and moved to liquid nitrogen. After four
weeks, we used media at 37°C or 4°C for initial dilution
of cells after thawing. The thawed cells were either
rested overnight at 37°C or not rested. The recovery
efficiency and T cell function were evaluated by deter-
mining cell viability, background levels, peptide
responses, and mitogen responses in ELISPOT assays,
respectively. We observed significantly lower cell viabi-
lity when using freezing Medium 4 and 5, compared to
the other media tested (Medium 5 vs Media 1-4:
P<0.001; Medium 4 vs 1: P<0.001, Medium 4 vs 2
P<0.05). Resting cells for 5 hours prior to freezing
resulted in higher viability, however this difference was
not significant (P=0.072). Using media warmed to 37°C
to dilute thawed samples resulted in significantly higher
cell viability as compared to using media at 4°C
(P<0.0001). Media 2 and 3 gave significantly lower back-
ground than Fresh cells (P<0.05). Medium 3 was the
only freezing medium to result in similar levels of
IGF1R peptide responses compared to Fresh. Overnight
resting of cryopreserved cells before ELISPOT gave
significantly lower T cells responses in both PHA and
PMA/ionomycin controls compared to unrested cryo-
preserved cells (P<0.001).However, overnight resting
of cells gave mitogen responses most similar to that
of fresh cells when PHA or PMA/ionomycin controls
were used. The method of cryopreservation can have
a tremendous impact upon splenocytes viability
and function. By using an optimized cryopreservation
protocol, it is possible to obtain antigen-specific T cell
function at levels similar to freshly isolated cells.
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